Application 217041
- Type
- ANDA
- Sponsor
- FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO.,
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | SITAGLIPTIN | SITAGLIPTIN PHOSPHATE | TABLET | 50MG | No | No |
| 003 | SITAGLIPTIN | SITAGLIPTIN PHOSPHATE | TABLET | 100MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sitagliptin Phosphate | SITAGLIPTIN PHOSPHATE | Sandoz Inc | cebc8388-c9db-4e27-8d6b-0d9bdc9d766d | 2026-05-10 | Warnings, Adverse reactions | SITAGLIPTIN PHOSPHATE |
| Sitagliptin | SITAGLIPTIN | Apotex Corp. | 983e9e14-e9bd-3136-e573-98b4dc67860b | 2026-04-14 | Warnings, Adverse reactions | Sitagliptin |
| Sitagliptin | SITAGLIPTIN | Teva Pharmaceuticals, Inc. | 5fa5aa67-455e-4ac6-864d-268a91286432 | 2025-12-01 | Warnings, Adverse reactions | Sitagliptin |
| Sitagliptin | SITAGLIPTIN | Zydus Pharmaceuticals (USA) Inc. | 6a970e80-b753-48fa-9fff-87e7a5044982 | 2025-01-31 | Warnings, Adverse reactions | Sitagliptin |
| Sitagliptin | SITAGLIPTIN | Zydus Lifesciences Limited | e5ac97e8-3a0b-4750-8e3f-337412570746 | 2025-01-31 | Warnings, Adverse reactions | Sitagliptin |